These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36798180)

  • 1. Rapid lethality of mice lacking the phagocyte oxidase and Caspase1/11 following
    Thomas SM; Olive AJ
    bioRxiv; 2023 Feb; ():. PubMed ID: 36798180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Lethality of
    Thomas SM; Olive AJ
    Infect Immun; 2023 Jul; 91(7):e0006023. PubMed ID: 37314361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst.
    Ng VH; Cox JS; Sousa AO; MacMicking JD; McKinney JD
    Mol Microbiol; 2004 Jun; 52(5):1291-302. PubMed ID: 15165233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
    Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
    Front Immunol; 2014; 5():180. PubMed ID: 24795723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Phagocyte Oxidase Controls Tolerance to
    Olive AJ; Smith CM; Kiritsy MC; Sassetti CM
    J Immunol; 2018 Sep; 201(6):1705-1716. PubMed ID: 30061198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis PPE51 Inhibits Autophagy by Suppressing Toll-Like Receptor 2-Dependent Signaling.
    Strong EJ; Wang J; Ng TW; Porcelli SA; Lee S
    mBio; 2022 Jun; 13(3):e0297421. PubMed ID: 35467412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits.
    Subbian S; Bandyopadhyay N; Tsenova L; O'Brien P; Khetani V; Kushner NL; Peixoto B; Soteropoulos P; Bader JS; Karakousis PC; Fallows D; Kaplan G
    Cell Commun Signal; 2013 Aug; 11():60. PubMed ID: 23958185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagy-promoting cytokine (IFN-gamma) and nitric oxide (NO) levels and reducing Th2 autophagy-restraining cytokines (IL-4 and IL-13) in response to Mycobacterium tuberculosis antigen.
    Ghadimi D; de Vrese M; Heller KJ; Schrezenmeir J
    Int Immunopharmacol; 2010 Jun; 10(6):694-706. PubMed ID: 20381647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis infection up-regulates MFN2 expression to promote NLRP3 inflammasome formation.
    Xu F; Qi H; Li J; Sun L; Gong J; Chen Y; Shen A; Li W
    J Biol Chem; 2020 Dec; 295(51):17684-17697. PubMed ID: 33454007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Shim D; Kim H; Shin SJ
    Front Immunol; 2020; 11():910. PubMed ID: 32477367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Sirt1 in innate immune mechanisms against Mycobacterium tuberculosis via the inhibition of TAK1 activation.
    Yang H; Hu J; Chen YJ; Ge B
    Arch Biochem Biophys; 2019 May; 667():49-58. PubMed ID: 31029687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis.
    Dorhoi A; Nouailles G; Jörg S; Hagens K; Heinemann E; Pradl L; Oberbeck-Müller D; Duque-Correa MA; Reece ST; Ruland J; Brosch R; Tschopp J; Gross O; Kaufmann SH
    Eur J Immunol; 2012 Feb; 42(2):374-84. PubMed ID: 22101787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.
    Bian Y; Shang S; Siddiqui S; Zhao J; Joosten SA; Ottenhoff THM; Cantor H; Wang CR
    PLoS Pathog; 2017 May; 13(5):e1006384. PubMed ID: 28475642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis inhibits the NLRP3 inflammasome activation via its phosphokinase PknF.
    Rastogi S; Ellinwood S; Augenstreich J; Mayer-Barber KD; Briken V
    PLoS Pathog; 2021 Jul; 17(7):e1009712. PubMed ID: 34324582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.